Virax Biolabs Group Ltd (VRAX)
1.16
-0.02
(-1.69%)
USD |
NASDAQ |
Jun 28, 16:00
1.15
-0.01
(-0.86%)
After-Hours: 20:00
Virax Biolabs Group Price to Book Value
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| June 28, 2024 | 0.3318 |
| June 27, 2024 | 0.3375 |
| June 26, 2024 | 0.3518 |
| June 25, 2024 | 0.3804 |
| June 24, 2024 | 0.369 |
| June 21, 2024 | 0.4291 |
| June 20, 2024 | 0.492 |
| June 18, 2024 | 0.492 |
| June 17, 2024 | 0.492 |
| June 14, 2024 | 0.5177 |
| June 13, 2024 | 0.4948 |
| June 12, 2024 | 0.4805 |
| June 11, 2024 | 0.4691 |
| June 10, 2024 | 0.552 |
| June 07, 2024 | 0.5635 |
| June 06, 2024 | 0.5635 |
| June 05, 2024 | 0.3061 |
| June 04, 2024 | 0.3003 |
| June 03, 2024 | 0.2975 |
| May 31, 2024 | 0.3375 |
| May 30, 2024 | 0.3118 |
| May 29, 2024 | 0.2632 |
| May 28, 2024 | 0.2546 |
| May 24, 2024 | 0.2574 |
| May 23, 2024 | 0.2383 |
| Date | Value |
|---|---|
| May 22, 2024 | 0.2446 |
| May 21, 2024 | 0.2263 |
| May 20, 2024 | 0.2374 |
| May 17, 2024 | 0.2401 |
| May 16, 2024 | 0.2241 |
| May 15, 2024 | 0.2245 |
| May 14, 2024 | 0.216 |
| May 13, 2024 | 0.2269 |
| May 10, 2024 | 0.2288 |
| May 09, 2024 | 0.1974 |
| May 08, 2024 | 0.2171 |
| May 07, 2024 | 0.2088 |
| May 06, 2024 | 0.1794 |
| May 03, 2024 | 0.1756 |
| May 02, 2024 | 0.1745 |
| May 01, 2024 | 0.1856 |
| April 30, 2024 | 0.1802 |
| April 29, 2024 | 0.1798 |
| April 26, 2024 | 0.1974 |
| April 25, 2024 | 0.2002 |
| April 24, 2024 | 0.1898 |
| April 23, 2024 | 0.1882 |
| April 22, 2024 | 0.2017 |
| April 19, 2024 | 0.1937 |
| April 18, 2024 | 0.1944 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.1745
Minimum
May 02 2024
8.363
Maximum
Sep 30 2022
1.306
Average
0.7216
Median
Price to Book Value Benchmarks
| Barinthus Biotherapeutics PLC | 0.318 |
| Adaptimmune Therapeutics PLC | 10.19 |
| Biodexa Pharmaceuticals Plc | 1.363 |
| Verona Pharma PLC | 5.211 |
| NuCana PLC | 0.4519 |
Price to Book Value Related Metrics
| Price | 1.16 |
| Market Cap | 2.101M |